Showing 1 - 20 results of 20 for search 'Yoshihiro Shirai', query time: 0.06s
Refine Results
-
1
-
2
Spontaneous Pathological Complete Regression of Hepatocellular Carcinoma by Tomohiko Taniai, Yoshihiro Shirai, Hiroaki Shiba, Taro Sakamoto, Kenei Furukawa, Katsuhiko Yanaga
Published 2018-11-01
Article -
3
-
4
Safe perioperative management of major hepatectomy in a patient with portal hypertension after elimination of hepatitis C: a case report by Ryoga Hamura, Shinji Onda, Yoshihiro Shirai, Jungo Yasuda, Koichiro Haruki, Kenei Furukawa, Taro Sakamoto, Takeshi Gocho, Toru Ikegami
Published 2022-01-01
Article -
5
Correction: Hiroshi Sugano et al. Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. Cancers 2018, 10,... by Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga
Published 2019-03-01
Article -
6
Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells by Hiroshi Sugano, Yoshihiro Shirai, Takashi Horiuchi, Nobuhiro Saito, Yohta Shimada, Ken Eto, Tadashi Uwagawa, Toya Ohashi, Katsuhiko Yanaga
Published 2018-10-01
Article -
7
Thrombectomized autologous portal Y-graft inflow construction can be an option in living-donor liver transplantation: a case report by Munetoshi Akaoka, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Shunta Ishizaki, Masashi Tsunematsu, Yoshihiro Shirai, Norimitsu Okui, Yoshiaki Tanji, Toru Ikegami
Published 2023-04-01
Article -
8
Significant impact of cachexia index on the outcomes after hepatic resection for colorectal liver metastases by Yoshiaki Tanji, Kenei Furukawa, Koichiro Haruki, Tomohiko Taniai, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Mitsuru Yanagaki, Yosuke Igarashi, Toru Ikegami
Published 2022-11-01
Article -
9
-
10
Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia by Yoshiaki Tanji, Kenei Furukawa, Yosuke Igarashi, Mitsuru Yanagaki, Koichiro Haruki, Yoshihiro Shirai, Tomohiko Taniai, Takeshi Gocho, Norimitsu Okui, Toru Ikegami
Published 2022-04-01
Article -
11
Occult Vertebral Fracture (OVF) in Patients Who Underwent Hepatectomy for Colorectal Liver Metastasis: Strong Association with Oncological Outcomes by Kenei Furukawa, Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, Masashi Tsunematsu, Yoshiaki Tanji, Shunta Ishizaki, Yoshihiro Shirai, Shinji Onda, Toru Ikegami
Published 2023-11-01
Article -
12
-
13
The impact of postoperative exocrine index on non‐alcoholic fatty liver disease following pancreaticoduodenectomy by Masashi Tsunematsu, Takeshi Gocho, Mitsuru Yanagaki, Yoshihiro Shirai, Koichiro Haruki, Kenei Furukawa, Jungo Yasuda, Shinji Onda, Taro Sakamoto, Toru Ikegami
Published 2022-09-01
Article -
14
Intracystic papillary neoplasm of the gallbladder concomitant with xanthogranulomatous cholecystitis: a case report by Takashi Aida, Masashi Tsunematsu, Kenei Furukawa, Koichiro Haruki, Yoshihiro Shirai, Shinji Onda, Yoichi Toyama, Kazutaka Gomisawa, Hiroyuki Takahashi, Toru Ikegami
Published 2021-10-01
Article -
15
Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases by Kenei Furukawa, Koichiro Haruki, Tomohiko Taniai, Ryoga Hamura, Yoshihiro Shirai, Jungo Yasuda, Hironori Shiozaki, Shinji Onda, Takeshi Gocho, Toru Ikegami
Published 2021-05-01
Article -
16
A novel combined C‐reactive protein‐albumin ratio and modified albumin‐bilirubin score can predict long‐term outcomes in patients with hepatocellular carcinoma after hepatic resect... by Takashi Aida, Koichiro Haruki, Munetoshi Akaoka, Kenei Furukawa, Shinji Onda, Yoshihiro Shirai, Hironori Shiozaki, Keita Takahashi, Tsunekazu Oikawa, Toru Ikegami
Published 2024-01-01
Article -
17
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer by Tadashi Uwagawa, Taro Sakamoto, Takeshi Gocho, Hiroaki Shiba, Shinji Onda, Jungo Yasuda, Yoshihiro Shirai, Ryoga Hamura, Kenei Furukawa, Katsuhiko Yanaga, Toru Ikegami
Published 2022-01-01
Article -
18
Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. by Naoki Takada, Hiroshi Sugano, Yoshihiro Shirai, Nobuhiro Saito, Ryoga Hamura, Tomohiko Taniai, Tadashi Uwagawa, Katsuhiko Yanaga, Toru Ikegami, Toya Ohashi, Ken Eto
Published 2021-01-01
Article -
19
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer. by Tadashi Uwagawa, Taro Sakamoto, Takeshi Gocho, Hiroaki Shiba, Shinji Onda, Jungo Yasuda, Yoshihiro Shirai, Ryoga Hamura, Kenei Furukawa, Katsuhiko Yanaga, Toru Ikegami
Published 2022-01-01
Article -
20
The impact of C‐reactive protein‐albumin‐lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy by Masashi Tsunematsu, Koichiro Haruki, Tomohiko Taniai, Yoshiaki Tanji, Yoshihiro Shirai, Kenei Furukawa, Tadashi Uwagawa, Shinji Onda, Mitsuru Yanagaki, Teruyuki Usuba, Yukio Nakabayashi, Tomoyoshi Okamoto, Toru Ikegami
Published 2023-05-01
Article